Why the study?
How do different classes of cardiovascular drugs affect insulin resistance and lipid profiles?
How do different classes of cardiovascular drugs affect insulin resistance and lipid profiles?
Different classes of antihypertensive drugs have divergent effects on insulin sensitivity, with beta-blockers and thiazides worsening it, which may have implications for cardiovascular risk.
Answers are grounded in this paper and cite their sources.
Antihypertensive selection may warrant caution in patients with insulin resistance; leaves open whether these metabolic differences alter cardiovascular outcomes.
Under certain circumstances the effect of insulin to promote glucose uptake in peripheral tissues is reduced because of a resistance to insulin action. This insulin resistance and the resulting hyperinsulinaemia are now recognised as common background factors that may be responsible for hypertension, hyperlipidaemia, decreased thrombolysis and also impaired glucose tolerance and diabetes. Hyperinsulinaemia has also been identified as an independent risk factor for coronary heart disease and promotes smooth muscle cell growth and plaque formation. A series of studies have now demonstrated that treatment with selective beta-blockers as well as thiazide diuretics impair insulin sensitivity by 15-30% and causes a compensatory increase in insulin concentrations. Furthermore, lipoprotein concentrations are affected in an unfavourable way. This is in contrast to the drugs belonging to ACE-inhibitors, calcium-channel blockers and alpha 1-blocker classes that are either neutral or may have the opposite effects in these respects.
No takes yet. Share an insight, caveat, or question.
Hans Lithell (1992) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: